nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—GRIN2B—Parkinson's disease	0.467	0.654	CbGaD
Ketamine—DRD2—Parkinson's disease	0.164	0.23	CbGaD
Ketamine—ABCB1—Parkinson's disease	0.0829	0.116	CbGaD
Ketamine—GRIN1—telencephalic ventricle—Parkinson's disease	0.00467	0.0405	CbGeAlD
Ketamine—GRIN2B—telencephalic ventricle—Parkinson's disease	0.00445	0.0386	CbGeAlD
Ketamine—SLC6A2—locus ceruleus—Parkinson's disease	0.00365	0.0317	CbGeAlD
Ketamine—GRIN2C—nerve—Parkinson's disease	0.00355	0.0308	CbGeAlD
Ketamine—TACR1—peripheral nervous system—Parkinson's disease	0.00345	0.03	CbGeAlD
Ketamine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00289	0.0251	CbGeAlD
Ketamine—GRIN2B—nerve—Parkinson's disease	0.00281	0.0244	CbGeAlD
Ketamine—TACR1—nerve—Parkinson's disease	0.00269	0.0234	CbGeAlD
Ketamine—GRIN2C—hindbrain—Parkinson's disease	0.00266	0.0231	CbGeAlD
Ketamine—GRIN2D—hindbrain—Parkinson's disease	0.00247	0.0215	CbGeAlD
Ketamine—GRIN2A—nerve—Parkinson's disease	0.00245	0.0213	CbGeAlD
Ketamine—OPRM1—telencephalic ventricle—Parkinson's disease	0.00237	0.0205	CbGeAlD
Ketamine—GRIN1—hindbrain—Parkinson's disease	0.0022	0.0191	CbGeAlD
Ketamine—GRIN2B—hindbrain—Parkinson's disease	0.0021	0.0182	CbGeAlD
Ketamine—SLC6A2—autonomic nervous system—Parkinson's disease	0.00194	0.0168	CbGeAlD
Ketamine—GRIN2A—hindbrain—Parkinson's disease	0.00184	0.0159	CbGeAlD
Ketamine—DRD2—telencephalic ventricle—Parkinson's disease	0.00158	0.0137	CbGeAlD
Ketamine—GRIN2C—brainstem—Parkinson's disease	0.00152	0.0132	CbGeAlD
Ketamine—OPRM1—nerve—Parkinson's disease	0.00149	0.0129	CbGeAlD
Ketamine—GRIN2C—forebrain—Parkinson's disease	0.00147	0.0128	CbGeAlD
Ketamine—GRIN2D—brainstem—Parkinson's disease	0.00142	0.0123	CbGeAlD
Ketamine—GRIN2D—forebrain—Parkinson's disease	0.00137	0.0119	CbGeAlD
Ketamine—GRIN3A—forebrain—Parkinson's disease	0.00129	0.0112	CbGeAlD
Ketamine—GRIN1—brainstem—Parkinson's disease	0.00126	0.011	CbGeAlD
Ketamine—GRIN1—forebrain—Parkinson's disease	0.00122	0.0106	CbGeAlD
Ketamine—GRIN2B—brainstem—Parkinson's disease	0.00121	0.0105	CbGeAlD
Ketamine—GRIN2B—forebrain—Parkinson's disease	0.00116	0.0101	CbGeAlD
Ketamine—TACR1—brainstem—Parkinson's disease	0.00116	0.01	CbGeAlD
Ketamine—TACR1—forebrain—Parkinson's disease	0.00112	0.00968	CbGeAlD
Ketamine—SLC6A2—nerve—Parkinson's disease	0.00109	0.00948	CbGeAlD
Ketamine—GRIN2C—medulla oblongata—Parkinson's disease	0.00106	0.00922	CbGeAlD
Ketamine—GRIN2A—brainstem—Parkinson's disease	0.00105	0.00914	CbGeAlD
Ketamine—GRIN2A—forebrain—Parkinson's disease	0.00102	0.00882	CbGeAlD
Ketamine—DRD2—nerve—Parkinson's disease	0.000995	0.00864	CbGeAlD
Ketamine—GRIN2D—medulla oblongata—Parkinson's disease	0.000988	0.00857	CbGeAlD
Ketamine—OPRD1—forebrain—Parkinson's disease	0.000906	0.00786	CbGeAlD
Ketamine—GRIN2D—spinal cord—Parkinson's disease	0.000881	0.00765	CbGeAlD
Ketamine—OPRK1—forebrain—Parkinson's disease	0.000869	0.00754	CbGeAlD
Ketamine—GRIN2C—head—Parkinson's disease	0.000843	0.00731	CbGeAlD
Ketamine—GRIN1—midbrain—Parkinson's disease	0.000805	0.00699	CbGeAlD
Ketamine—GRIN2C—nervous system—Parkinson's disease	0.000799	0.00693	CbGeAlD
Ketamine—GRIN1—spinal cord—Parkinson's disease	0.000786	0.00682	CbGeAlD
Ketamine—GRIN2D—head—Parkinson's disease	0.000783	0.0068	CbGeAlD
Ketamine—GRIN2C—central nervous system—Parkinson's disease	0.000769	0.00667	CbGeAlD
Ketamine—GRIN2C—cerebellum—Parkinson's disease	0.000752	0.00652	CbGeAlD
Ketamine—GRIN2B—spinal cord—Parkinson's disease	0.000749	0.0065	CbGeAlD
Ketamine—DRD2—hindbrain—Parkinson's disease	0.000746	0.00647	CbGeAlD
Ketamine—GRIN2D—nervous system—Parkinson's disease	0.000743	0.00644	CbGeAlD
Ketamine—GRIN3A—head—Parkinson's disease	0.000737	0.00639	CbGeAlD
Ketamine—GRIN2A—medulla oblongata—Parkinson's disease	0.000735	0.00637	CbGeAlD
Ketamine—TACR1—spinal cord—Parkinson's disease	0.000719	0.00623	CbGeAlD
Ketamine—GRIN2D—central nervous system—Parkinson's disease	0.000715	0.0062	CbGeAlD
Ketamine—GRIN2D—cerebellum—Parkinson's disease	0.000699	0.00606	CbGeAlD
Ketamine—GRIN3A—nervous system—Parkinson's disease	0.000698	0.00606	CbGeAlD
Ketamine—GRIN1—head—Parkinson's disease	0.000698	0.00606	CbGeAlD
Ketamine—GRIN3A—central nervous system—Parkinson's disease	0.000672	0.00583	CbGeAlD
Ketamine—GRIN2A—midbrain—Parkinson's disease	0.000671	0.00582	CbGeAlD
Ketamine—GRIN2B—head—Parkinson's disease	0.000666	0.00578	CbGeAlD
Ketamine—GRIN1—nervous system—Parkinson's disease	0.000662	0.00574	CbGeAlD
Ketamine—GRIN2A—spinal cord—Parkinson's disease	0.000655	0.00568	CbGeAlD
Ketamine—OPRM1—brainstem—Parkinson's disease	0.00064	0.00556	CbGeAlD
Ketamine—TACR1—head—Parkinson's disease	0.000639	0.00554	CbGeAlD
Ketamine—GRIN1—central nervous system—Parkinson's disease	0.000637	0.00553	CbGeAlD
Ketamine—GRIN2B—nervous system—Parkinson's disease	0.000631	0.00548	CbGeAlD
Ketamine—GRIN1—cerebellum—Parkinson's disease	0.000623	0.0054	CbGeAlD
Ketamine—OPRM1—forebrain—Parkinson's disease	0.000618	0.00536	CbGeAlD
Ketamine—GRIN2C—brain—Parkinson's disease	0.000611	0.0053	CbGeAlD
Ketamine—GRIN2B—central nervous system—Parkinson's disease	0.000608	0.00527	CbGeAlD
Ketamine—TACR1—nervous system—Parkinson's disease	0.000605	0.00525	CbGeAlD
Ketamine—GRIN2B—cerebellum—Parkinson's disease	0.000594	0.00516	CbGeAlD
Ketamine—TACR1—central nervous system—Parkinson's disease	0.000583	0.00506	CbGeAlD
Ketamine—GRIN2A—head—Parkinson's disease	0.000582	0.00505	CbGeAlD
Ketamine—GRIN2D—brain—Parkinson's disease	0.000568	0.00492	CbGeAlD
Ketamine—GRIN2A—nervous system—Parkinson's disease	0.000552	0.00479	CbGeAlD
Ketamine—GRIN3A—brain—Parkinson's disease	0.000534	0.00463	CbGeAlD
Ketamine—GRIN2A—central nervous system—Parkinson's disease	0.000531	0.00461	CbGeAlD
Ketamine—GRIN2A—cerebellum—Parkinson's disease	0.000519	0.00451	CbGeAlD
Ketamine—OPRD1—head—Parkinson's disease	0.000519	0.0045	CbGeAlD
Ketamine—GRIN1—brain—Parkinson's disease	0.000506	0.00439	CbGeAlD
Ketamine—OPRK1—head—Parkinson's disease	0.000497	0.00432	CbGeAlD
Ketamine—OPRD1—nervous system—Parkinson's disease	0.000492	0.00427	CbGeAlD
Ketamine—GRIN2B—brain—Parkinson's disease	0.000483	0.00419	CbGeAlD
Ketamine—OPRD1—central nervous system—Parkinson's disease	0.000474	0.00411	CbGeAlD
Ketamine—OPRK1—nervous system—Parkinson's disease	0.000472	0.00409	CbGeAlD
Ketamine—SLC6A2—brainstem—Parkinson's disease	0.000469	0.00407	CbGeAlD
Ketamine—TACR1—brain—Parkinson's disease	0.000463	0.00401	CbGeAlD
Ketamine—OPRK1—central nervous system—Parkinson's disease	0.000454	0.00394	CbGeAlD
Ketamine—SLC6A2—forebrain—Parkinson's disease	0.000453	0.00393	CbGeAlD
Ketamine—OPRK1—cerebellum—Parkinson's disease	0.000444	0.00385	CbGeAlD
Ketamine—DRD2—brainstem—Parkinson's disease	0.000427	0.00371	CbGeAlD
Ketamine—GRIN2A—brain—Parkinson's disease	0.000422	0.00366	CbGeAlD
Ketamine—DRD2—forebrain—Parkinson's disease	0.000412	0.00358	CbGeAlD
Ketamine—OPRM1—midbrain—Parkinson's disease	0.000408	0.00354	CbGeAlD
Ketamine—OPRM1—spinal cord—Parkinson's disease	0.000398	0.00345	CbGeAlD
Ketamine—OPRD1—brain—Parkinson's disease	0.000376	0.00326	CbGeAlD
Ketamine—OPRK1—brain—Parkinson's disease	0.000361	0.00313	CbGeAlD
Ketamine—OPRM1—head—Parkinson's disease	0.000354	0.00307	CbGeAlD
Ketamine—OPRM1—nervous system—Parkinson's disease	0.000336	0.00291	CbGeAlD
Ketamine—SLC6A2—medulla oblongata—Parkinson's disease	0.000327	0.00284	CbGeAlD
Ketamine—OPRM1—central nervous system—Parkinson's disease	0.000323	0.0028	CbGeAlD
Ketamine—PTGS1—forebrain—Parkinson's disease	0.000301	0.00262	CbGeAlD
Ketamine—CYP2B6—cardiovascular system—Parkinson's disease	0.000282	0.00245	CbGeAlD
Ketamine—CYP2C9—cardiovascular system—Parkinson's disease	0.000279	0.00242	CbGeAlD
Ketamine—DRD2—midbrain—Parkinson's disease	0.000272	0.00236	CbGeAlD
Ketamine—SLC6A2—head—Parkinson's disease	0.000259	0.00225	CbGeAlD
Ketamine—OPRM1—brain—Parkinson's disease	0.000256	0.00222	CbGeAlD
Ketamine—PTGS1—cardiovascular system—Parkinson's disease	0.000255	0.00221	CbGeAlD
Ketamine—SLC6A2—nervous system—Parkinson's disease	0.000246	0.00213	CbGeAlD
Ketamine—SLC6A2—central nervous system—Parkinson's disease	0.000237	0.00205	CbGeAlD
Ketamine—DRD2—head—Parkinson's disease	0.000236	0.00205	CbGeAlD
Ketamine—DRD2—nervous system—Parkinson's disease	0.000224	0.00194	CbGeAlD
Ketamine—DRD2—central nervous system—Parkinson's disease	0.000216	0.00187	CbGeAlD
Ketamine—DRD2—cerebellum—Parkinson's disease	0.000211	0.00183	CbGeAlD
Ketamine—ABCB1—embryo—Parkinson's disease	0.000202	0.00175	CbGeAlD
Ketamine—PTGS1—spinal cord—Parkinson's disease	0.000194	0.00169	CbGeAlD
Ketamine—CYP2B6—head—Parkinson's disease	0.000191	0.00166	CbGeAlD
Ketamine—SLC6A2—brain—Parkinson's disease	0.000188	0.00163	CbGeAlD
Ketamine—CYP2B6—nervous system—Parkinson's disease	0.000181	0.00157	CbGeAlD
Ketamine—ABCB1—forebrain—Parkinson's disease	0.000178	0.00155	CbGeAlD
Ketamine—CYP2B6—central nervous system—Parkinson's disease	0.000174	0.00151	CbGeAlD
Ketamine—PTGS1—head—Parkinson's disease	0.000173	0.0015	CbGeAlD
Ketamine—DRD2—brain—Parkinson's disease	0.000171	0.00148	CbGeAlD
Ketamine—PTGS1—nervous system—Parkinson's disease	0.000164	0.00142	CbGeAlD
Ketamine—PTGS1—central nervous system—Parkinson's disease	0.000158	0.00137	CbGeAlD
Ketamine—CYP2C8—brain—Parkinson's disease	0.000154	0.00134	CbGeAlD
Ketamine—ABCB1—cardiovascular system—Parkinson's disease	0.000151	0.00131	CbGeAlD
Ketamine—CYP2B6—brain—Parkinson's disease	0.000138	0.0012	CbGeAlD
Ketamine—CYP3A4—nervous system—Parkinson's disease	0.000137	0.00119	CbGeAlD
Ketamine—CYP3A4—central nervous system—Parkinson's disease	0.000132	0.00114	CbGeAlD
Ketamine—ABCB1—medulla oblongata—Parkinson's disease	0.000129	0.00112	CbGeAlD
Ketamine—PTGS1—brain—Parkinson's disease	0.000125	0.00109	CbGeAlD
Ketamine—ABCB1—midbrain—Parkinson's disease	0.000118	0.00102	CbGeAlD
Ketamine—ABCB1—spinal cord—Parkinson's disease	0.000115	0.000996	CbGeAlD
Ketamine—ABCB1—head—Parkinson's disease	0.000102	0.000885	CbGeAlD
Ketamine—ABCB1—nervous system—Parkinson's disease	9.68e-05	0.000839	CbGeAlD
Ketamine—ABCB1—central nervous system—Parkinson's disease	9.32e-05	0.000808	CbGeAlD
Ketamine—ABCB1—cerebellum—Parkinson's disease	9.11e-05	0.00079	CbGeAlD
Ketamine—ABCB1—brain—Parkinson's disease	7.4e-05	0.000642	CbGeAlD
Ketamine—OPRM1—GPCR downstream signaling—EDN1—Parkinson's disease	1.4e-05	8.2e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD3—Parkinson's disease	1.4e-05	8.2e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—INSR—Parkinson's disease	1.39e-05	8.17e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	1.37e-05	8.05e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GCH1—Parkinson's disease	1.37e-05	8.03e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	1.37e-05	8.01e-05	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TNF—Parkinson's disease	1.37e-05	8.01e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.37e-05	8.01e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PENK—Parkinson's disease	1.34e-05	7.85e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAG—Parkinson's disease	1.34e-05	7.85e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	1.33e-05	7.79e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	1.32e-05	7.76e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—FGB—Parkinson's disease	1.32e-05	7.72e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FGF20—Parkinson's disease	1.32e-05	7.72e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HTR2A—Parkinson's disease	1.31e-05	7.71e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HTR1A—Parkinson's disease	1.31e-05	7.68e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—FBP1—Parkinson's disease	1.31e-05	7.66e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GBA—Parkinson's disease	1.31e-05	7.66e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—DBH—Parkinson's disease	1.31e-05	7.66e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ADRBK1—Parkinson's disease	1.31e-05	7.65e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—DDC—Parkinson's disease	1.3e-05	7.63e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TAC1—Parkinson's disease	1.29e-05	7.57e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ADORA2A—Parkinson's disease	1.28e-05	7.48e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EDN1—Parkinson's disease	1.27e-05	7.45e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD1—Parkinson's disease	1.27e-05	7.42e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD2—Parkinson's disease	1.26e-05	7.41e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HTR7—Parkinson's disease	1.26e-05	7.41e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—INS—Parkinson's disease	1.25e-05	7.32e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	1.24e-05	7.28e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.24e-05	7.25e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTA4—Parkinson's disease	1.23e-05	7.2e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD3—Parkinson's disease	1.23e-05	7.19e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PDYN—Parkinson's disease	1.22e-05	7.18e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.22e-05	7.17e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GBA—Parkinson's disease	1.22e-05	7.16e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—FBP1—Parkinson's disease	1.22e-05	7.16e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—DBH—Parkinson's disease	1.22e-05	7.16e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	1.2e-05	7.05e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—INSR—Parkinson's disease	1.18e-05	6.91e-05	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	1.17e-05	6.86e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GFAP—Parkinson's disease	1.15e-05	6.75e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ADRBK1—Parkinson's disease	1.14e-05	6.71e-05	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.14e-05	6.7e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GRM5—Parkinson's disease	1.14e-05	6.67e-05	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—IL6—Parkinson's disease	1.13e-05	6.63e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FGB—Parkinson's disease	1.11e-05	6.53e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HTR2A—Parkinson's disease	1.11e-05	6.51e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD2—Parkinson's disease	1.11e-05	6.5e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HTR7—Parkinson's disease	1.11e-05	6.5e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HTR1A—Parkinson's disease	1.11e-05	6.49e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	1.11e-05	6.48e-05	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—IL6—Parkinson's disease	1.1e-05	6.46e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—DDC—Parkinson's disease	1.1e-05	6.46e-05	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.1e-05	6.43e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—MAOB—Parkinson's disease	1.09e-05	6.42e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TAC1—Parkinson's disease	1.09e-05	6.4e-05	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	1.08e-05	6.31e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD1—Parkinson's disease	1.07e-05	6.27e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CYP2D6—Parkinson's disease	1.07e-05	6.25e-05	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	1.07e-05	6.25e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.06e-05	6.23e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ND3—Parkinson's disease	1.06e-05	6.23e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	1.06e-05	6.21e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IGF2—Parkinson's disease	1.06e-05	6.21e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CTGF—Parkinson's disease	1.05e-05	6.14e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTA4—Parkinson's disease	1.04e-05	6.1e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	1.04e-05	6.07e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.03e-05	6.02e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IGF1R—Parkinson's disease	1.02e-05	6.01e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EDN1—Parkinson's disease	1.01e-05	5.93e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	9.99e-06	5.86e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—OMD—Parkinson's disease	9.99e-06	5.86e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGF20—Parkinson's disease	9.98e-06	5.85e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CYP2E1—Parkinson's disease	9.75e-06	5.72e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	9.67e-06	5.67e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	9.67e-06	5.67e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NQO1—Parkinson's disease	9.64e-06	5.66e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	9.62e-06	5.64e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—DDC—Parkinson's disease	9.59e-06	5.63e-05	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.53e-06	5.59e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—TH—Parkinson's disease	9.5e-06	5.57e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	9.47e-06	5.55e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	9.37e-06	5.49e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	9.37e-06	5.49e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	9.36e-06	5.49e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NGF—Parkinson's disease	9.3e-06	5.45e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CASP3—Parkinson's disease	9.3e-06	5.45e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IGF2—Parkinson's disease	9.29e-06	5.45e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	9.27e-06	5.44e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MAOB—Parkinson's disease	9.27e-06	5.43e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL6—Parkinson's disease	9.23e-06	5.41e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CYCS—Parkinson's disease	9.13e-06	5.35e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTA4—Parkinson's disease	9.06e-06	5.31e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GCH1—Parkinson's disease	9.03e-06	5.3e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IGF1R—Parkinson's disease	8.98e-06	5.27e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—DDC—Parkinson's disease	8.96e-06	5.25e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—INSR—Parkinson's disease	8.93e-06	5.23e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EDN1—Parkinson's disease	8.87e-06	5.2e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HTR2A—Parkinson's disease	8.85e-06	5.19e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	8.82e-06	5.17e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MAPK8—Parkinson's disease	8.54e-06	5.01e-05	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	8.51e-06	4.99e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	8.46e-06	4.96e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGB—Parkinson's disease	8.44e-06	4.95e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	8.42e-06	4.94e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	8.39e-06	4.92e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	8.36e-06	4.9e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TAC1—Parkinson's disease	8.27e-06	4.85e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—APOE—Parkinson's disease	8.23e-06	4.83e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	8.16e-06	4.78e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NGF—Parkinson's disease	8.16e-06	4.78e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	8.14e-06	4.77e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	8.11e-06	4.75e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—COMT—Parkinson's disease	8.08e-06	4.74e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MAOB—Parkinson's disease	8.07e-06	4.73e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GBA—Parkinson's disease	8.05e-06	4.72e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—FBP1—Parkinson's disease	8.05e-06	4.72e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—DBH—Parkinson's disease	8.05e-06	4.72e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GSTP1—Parkinson's disease	8.04e-06	4.72e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—MAOA—Parkinson's disease	8.02e-06	4.71e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CTGF—Parkinson's disease	7.99e-06	4.68e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—HMOX1—Parkinson's disease	7.93e-06	4.65e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	7.85e-06	4.6e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	7.85e-06	4.6e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HTR2A—Parkinson's disease	7.76e-06	4.55e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	7.62e-06	4.47e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ABCB1—Parkinson's disease	7.61e-06	4.46e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	7.59e-06	4.45e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MAOB—Parkinson's disease	7.54e-06	4.42e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	7.5e-06	4.4e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	7.44e-06	4.36e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GSTM1—Parkinson's disease	7.39e-06	4.33e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NQO1—Parkinson's disease	7.36e-06	4.31e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	7.33e-06	4.3e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—TH—Parkinson's disease	7.25e-06	4.25e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—APOE—Parkinson's disease	7.22e-06	4.23e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	7.18e-06	4.21e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	7.1e-06	4.16e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GPX1—Parkinson's disease	7.08e-06	4.15e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—INS—Parkinson's disease	7.03e-06	4.12e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CYCS—Parkinson's disease	6.96e-06	4.08e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NGF—Parkinson's disease	6.89e-06	4.04e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	6.89e-06	4.04e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CTGF—Parkinson's disease	6.76e-06	3.96e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	6.56e-06	3.85e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—MTHFR—Parkinson's disease	6.53e-06	3.83e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	6.3e-06	3.69e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NQO1—Parkinson's disease	6.23e-06	3.65e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—COMT—Parkinson's disease	6.17e-06	3.62e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—INS—Parkinson's disease	6.17e-06	3.62e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—TH—Parkinson's disease	6.14e-06	3.6e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTP1—Parkinson's disease	6.14e-06	3.6e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—MAOA—Parkinson's disease	6.12e-06	3.59e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APOE—Parkinson's disease	6.1e-06	3.58e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—APOE—Parkinson's disease	6.08e-06	3.57e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—HMOX1—Parkinson's disease	6.05e-06	3.55e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	6e-06	3.52e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	5.95e-06	3.49e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—DDC—Parkinson's disease	5.91e-06	3.47e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYCS—Parkinson's disease	5.89e-06	3.46e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CTGF—Parkinson's disease	5.89e-06	3.45e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ABCB1—Parkinson's disease	5.81e-06	3.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	5.75e-06	3.37e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	5.68e-06	3.33e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTM1—Parkinson's disease	5.64e-06	3.31e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	5.61e-06	3.29e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	5.58e-06	3.27e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CTGF—Parkinson's disease	5.5e-06	3.23e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	5.49e-06	3.22e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL6—Parkinson's disease	5.46e-06	3.2e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NQO1—Parkinson's disease	5.43e-06	3.18e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GPX1—Parkinson's disease	5.4e-06	3.17e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TH—Parkinson's disease	5.35e-06	3.14e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CASP3—Parkinson's disease	5.24e-06	3.07e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NGF—Parkinson's disease	5.22e-06	3.06e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—COMT—Parkinson's disease	5.22e-06	3.06e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—INS—Parkinson's disease	5.21e-06	3.06e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—Parkinson's disease	5.2e-06	3.05e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTP1—Parkinson's disease	5.2e-06	3.05e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—INS—Parkinson's disease	5.2e-06	3.05e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MAOA—Parkinson's disease	5.18e-06	3.04e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYCS—Parkinson's disease	5.14e-06	3.01e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	5.13e-06	3.01e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—HMOX1—Parkinson's disease	5.12e-06	3e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NQO1—Parkinson's disease	5.07e-06	2.97e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	5.03e-06	2.95e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TH—Parkinson's disease	5e-06	2.93e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—MTHFR—Parkinson's disease	4.98e-06	2.92e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.97e-06	2.92e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	4.97e-06	2.92e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ABCB1—Parkinson's disease	4.92e-06	2.88e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK8—Parkinson's disease	4.81e-06	2.82e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYCS—Parkinson's disease	4.8e-06	2.81e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTM1—Parkinson's disease	4.77e-06	2.8e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—APOE—Parkinson's disease	4.64e-06	2.72e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APOE—Parkinson's disease	4.62e-06	2.71e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CASP3—Parkinson's disease	4.59e-06	2.69e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GPX1—Parkinson's disease	4.57e-06	2.68e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—Parkinson's disease	4.56e-06	2.67e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—COMT—Parkinson's disease	4.55e-06	2.67e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTP1—Parkinson's disease	4.53e-06	2.65e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MAOA—Parkinson's disease	4.52e-06	2.65e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HMOX1—Parkinson's disease	4.46e-06	2.62e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—COMT—Parkinson's disease	4.25e-06	2.49e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	4.23e-06	2.48e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MTHFR—Parkinson's disease	4.22e-06	2.47e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK8—Parkinson's disease	4.22e-06	2.47e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MAOA—Parkinson's disease	4.22e-06	2.47e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	4.17e-06	2.45e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTM1—Parkinson's disease	4.16e-06	2.44e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	4e-06	2.35e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GPX1—Parkinson's disease	3.98e-06	2.34e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—INS—Parkinson's disease	3.96e-06	2.32e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—INS—Parkinson's disease	3.95e-06	2.32e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—APOE—Parkinson's disease	3.93e-06	2.3e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	3.89e-06	2.28e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	3.88e-06	2.28e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	3.85e-06	2.26e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GPX1—Parkinson's disease	3.72e-06	2.18e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	3.7e-06	2.17e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MTHFR—Parkinson's disease	3.68e-06	2.16e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.63e-06	2.13e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	3.57e-06	2.09e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	3.43e-06	2.01e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—APOE—Parkinson's disease	3.42e-06	2.01e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.38e-06	1.98e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—INS—Parkinson's disease	3.36e-06	1.97e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.34e-06	1.96e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TH—Parkinson's disease	3.3e-06	1.93e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—APOE—Parkinson's disease	3.2e-06	1.87e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.16e-06	1.86e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—Parkinson's disease	3.07e-06	1.8e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.94e-06	1.72e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—INS—Parkinson's disease	2.92e-06	1.71e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.92e-06	1.71e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—COMT—Parkinson's disease	2.8e-06	1.64e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.79e-06	1.64e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.78e-06	1.63e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.75e-06	1.61e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—INS—Parkinson's disease	2.73e-06	1.6e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.7e-06	1.58e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—Parkinson's disease	2.69e-06	1.58e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.64e-06	1.55e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.56e-06	1.5e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.45e-06	1.44e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—Parkinson's disease	2.28e-06	1.34e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.26e-06	1.33e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APOE—Parkinson's disease	2.11e-06	1.24e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—INS—Parkinson's disease	1.8e-06	1.06e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.73e-06	1.01e-05	CbGpPWpGaD
